Insider Stock Trader

Insider sale RCKT

Rocket Pharmaceuticals, Inc. general counsel Martin Wilson trims stake with $127,813 sale

53,389 shares sold on the open market on Nov 5, at about $2.39 each.

Insider selling at Rocket Pharmaceuticals, Inc.: Martin Wilson, a general counsel, sold 53,389 shares on Nov 5 for $127,813, at an average of $2.39 a share, a Form 4 filed on Nov 9 shows.

The filing does not mark the sale as made under a Rule 10b5-1 trading plan. The filing came 4 days after the trade.

The insider still holds 545,100 shares after the sale, 8.9% fewer than before. It is the eighth insider sale at Rocket Pharmaceuticals, Inc. reported in the last 90 days.

Details from the SEC filing:

The sale
CompanyRocket Pharmaceuticals, Inc. (RCKT)
InsiderMartin Wilson
RoleGeneral Counsel
TransactionOpen-market sale (code S)
Shares53,389
Average price$2.39
Value$127,813
Trade dateNov 5, 2026
Filed with the SECNov 9, 2026, 4:05 PM ET
Shares held after545,100
OwnershipDirect
Rule 10b5-1 planNot marked in the filing

See this filing row by row in Insider Stock Trader

View the Form 4 on SEC.gov

Browse the insider trading newsroom · Read the daily insider trading roundup

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.